Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer

Article

Abstract: Prostate cancer resistance to castration occurs because tumours acquire the metabolic capability of

Palabras claves:

Autores:

Alyamani M., Bishop A., Bunch D., Dreicer R., Garcia J., Li Z., Liu J., Richard J. Auchus, Sharifi N., Upadhyay S.K.

Fuentes:

scopus